<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">636265</article-id><article-id pub-id-type="doi">10.17816/KMJ636265</article-id><article-id pub-id-type="edn">LNNPLA</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Theoretical and clinical medicine</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Теоретическая и клиническая медицина</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Clinical and Functional Characteristics of Patients Undergoing Multivisceral Surgery With Pancreaticoduodenectomy</article-title><trans-title-group xml:lang="ru"><trans-title>Клинико-функциональные особенности пациентов, перенёсших мультивисцеральную операцию с панкреатодуоденальной резекцией</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6603-1390</contrib-id><contrib-id contrib-id-type="spin">7794-4210</contrib-id><name-alternatives><name xml:lang="en"><surname>Egorov</surname><given-names>Vasily I.</given-names></name><name xml:lang="ru"><surname>Егоров</surname><given-names>Василий Иванович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine), Assistant Lecturer, Depart. of Oncology, Radiation Diagnostics and Radiation Therapy, Oncologist, oncology Depart. No. 11</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, ассистент, каф. онкологии, лучевой диагностики и лучевой терапии, врач-онколог, онкологическое отделение № 11</p></bio><email>drvasiliy21@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2811-0549</contrib-id><contrib-id contrib-id-type="spin">8710-4003</contrib-id><name-alternatives><name xml:lang="en"><surname>Kotelnikov</surname><given-names>Aleksey  G.</given-names></name><name xml:lang="ru"><surname>Котельников</surname><given-names>Алексей Геннадьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor, Leading research associate, Oncology Depart. of Abdominal Oncology No. 2</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, ведущий научный сотрудник, отделение абдоминальной онкологии № 2</p></bio><email>kotelnikovag@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9254-1346</contrib-id><name-alternatives><name xml:lang="en"><surname>Patyutko</surname><given-names>Yury I.</given-names></name><name xml:lang="ru"><surname>Патютко</surname><given-names>Юрий Иванович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Chief Researcher, Oncology Depart. of Abdominal Oncology No. 2</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, главный научный консультант, абдоминальная онкология № 2</p></bio><email>mikpat@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4516-1997</contrib-id><contrib-id contrib-id-type="spin">8908-4761</contrib-id><name-alternatives><name xml:lang="en"><surname>Akhmetzyanov</surname><given-names>Foat Sh.</given-names></name><name xml:lang="ru"><surname>Ахметзянов</surname><given-names>Фоат Шайхутдинович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor, Head of Depart., Department of Oncology, Radiation Diagnostics and Radiation Therapy, Head of the Surgical Clinic LDK2</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, зав. каф., каф. онкологии, лучевой диагностики и лучевой терапии, руководитель хирургической клиники ЛДК2</p></bio><email>akhmetzyanov@mail.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7375-3378</contrib-id><contrib-id contrib-id-type="spin">3537-3436</contrib-id><name-alternatives><name xml:lang="en"><surname>Podluzhnyi</surname><given-names>Danil V.</given-names></name><name xml:lang="ru"><surname>Подлужный</surname><given-names>Данил Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine), Head of the Oncology Depart. of Abdominal Oncology No. 2</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, зав. хирургическим отделением абдоминальной онкологии № 2</p></bio><email>danil-p@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Kazan State Medical University</institution></aff><aff><institution xml:lang="ru">Казанский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Republican Clinical Oncology Dispensary named after prof. M.Z. Sigal</institution></aff><aff><institution xml:lang="ru">Республиканский клинический онкологический диспансер им. проф. М.З. Сигала</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-04-29" publication-format="electronic"><day>29</day><month>04</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2025-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2025</year></pub-date><volume>106</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>367</fpage><lpage>374</lpage><history><date date-type="received" iso-8601-date="2024-09-19"><day>19</day><month>09</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-12-27"><day>27</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Эко-Вектор</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2028-06-15"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/636265">https://kazanmedjournal.ru/kazanmedj/article/view/636265</self-uri><abstract xml:lang="en"><p><bold><italic>BACKGROUND</italic></bold><italic>:</italic> Multivisceral procedures involving pancreaticoduodenectomy are associated with postoperative complications that worsen the general condition of patients, hinder specialized treatment initiation, and increase treatment-related risks.</p> <p><bold><italic>AIM:</italic></bold> To investigate the clinical and functional characteristics of patients undergoing multivisceral surgery with pancreaticoduodenectomy.</p> <p><bold><italic>MATERIAL AND METHODS:</italic></bold> The study included 251 patients who underwent multivisceral resection with pancreaticoduodenectomy (group 1) for tumors of various localizations between January 2011 and April 2024 at two institutions: National Medical Research Center of Oncology, named after N.N. Blokhin, and Republican Clinical Oncological Dispansery, named after Prof. M.Z. Sigal. The control group comprised 832 patients who underwent standard-volume pancreaticoduodenectomy (group 2) at the same institutions during the same period. The patients’ sex, age, ECOG performance status, ASA physical status classification, body mass index, comorbidities, tumor-related complications, and characteristics of the pancreatic remnant, which are major determinants of postoperative complications, were evaluated. Continuous variables are described using the median and lower and upper quartiles (Q1–Q3). Categorical variables are presented as absolute numbers and percentages. The continuous variables of the two groups were compared using the Mann–Whitney U test. Comparison of percentage distributions in 2×2 contingency tables was performed using Pearson’s χ² test. Differences were considered significant at <italic>p</italic><italic> &lt;</italic>0.05.</p> <p><bold><italic>RESULTS:</italic></bold> Group 1 had a significantly higher proportion of patients with ECOG scores of 2 (30.3 vs. 8.7%, <italic>p</italic><italic> &lt;</italic>0.001) and 3 (4.4 vs. 0.7%, <italic>p</italic><italic> &lt;</italic>0.001), a lower prevalence of obesity (8.8 vs. 15.7%), and fewer elderly patients (38.6 vs. 54.6%). Anemia (38.2 vs. 10.2%, <italic>p</italic><italic> &lt;</italic>0.001), tumor-related stenosis (19.5 vs. 2.5%, <italic>p</italic><italic> &lt;</italic>0.001), and enteric fistula or peritumoral abscess (10.4 vs. 0.6%, <italic>p</italic><italic> &lt;</italic>0.001) were significantly more common in group 1, whereas obstructive jaundice was more frequent in group 2 (47.8 vs. 69.5%, <italic>p</italic><italic> &lt;</italic>0.001). The pancreatic duct diameter was significantly smaller in group 1 (0.3 mm [0.2–0.4] vs. 0.4 mm [0.2–0.5], <italic>p</italic><italic> &lt;</italic>0.001), whereas pancreatic parenchymal density did not significantly differ between the groups.</p> <p><bold><italic>CONCLUSION:</italic></bold> Patients undergoing multivisceral surgery that includes pancreaticoduodenectomy represent a clinically more complex cohort with poorer overall functional status compared with those undergoing standard pancreaticoduodenectomy without adjacent organ resection.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность.</bold> Мультивисцеральные операции с панкреатодуоденальной резекцией часто сопровождаются осложнениями, что значительно ухудшает общее состояние больных и затрудняет в целом начало любого специализированного лечения и несёт риски в процессе его проведения.</p> <p><bold>Цель.</bold> Изучение клинико-функциональных особенностей больных, перенёсших мультивисцеральную операцию с панкреатодуоденальной резекцией.</p> <p><bold>Материал и методы.</bold> Включены все пациенты (251 больной), которые перенесли мультивисцеральную операцию с панкреатодуоденальной резекцией (1-я группа) по поводу опухолей различных локализаций с января 2011 г. по апрель 2024 г. в двух учреждениях: НМИЦ онкологии им. Н.Н. Блохина и ГАУЗ «РКОД МЗ РТ им. проф. М.З. Сигала». Для группы контроля выбрана когорта из 832 пациентов, перенёсших в указанный период панкреатодуоденальную резекцию в стандартном объёме (2-я группа) в указанных клиниках. Оценивали: пол, возраст, состояние по шкале ECOG, шкале риска ASA, индекс массы тела, сопутствующие заболевания, осложнения опухоли, а также характеристики культи поджелудочной железы в значительной степени определяющие послеоперационные осложнения. Количественные показатели описывали с помощью медианы (Ме) и нижнего и верхнего квартилей (Q1–Q3). Категориальные данные описывали с указанием абсолютных значений и процентных долей. Сравнение двух групп по количественному показателю выполняли с помощью U-критерия Манна–Уитни. Сравнение процентных долей при анализе четырёхпольных таблиц сопряжённости производили с помощью критерия хи-квадрат Пирсона. Различия показателей считали статистически значимыми при уровне <italic>p</italic> &lt;0,05.</p> <p><bold>Результаты.</bold> Достоверное различие выявлено по следующим параметрам: в 1-й группе больные чаще имели оценки по шкале ECOG 2 (30,3 против 8,7%, <italic>р</italic> &lt;0,001) и ECOG 3 (4,4 против 0,7%, <italic>p</italic> &lt;0,001); ожирение отмечалось реже (8,8 против 15,7%); доля лиц пожилого возраста была ниже (38,6 против 54,6%). В 1-й группе достоверно чаще встречалась анемия (38,2 против 10,2%, <italic>р</italic> &lt;0,001), опухолевый стеноз (19,5 против 2,5%, <italic>р</italic> &lt;0,001), внутренний кишечный свищ/параканкрозный абсцесс (10,4 против 0,6%, <italic>р</italic> &lt;0,001), во 2-й группе чаще наблюдалась механическая желтуха (47,8 против 69,5%, <italic>р</italic> &lt;0,001). Диаметр панкреатического протока был достоверно меньше в 1-й группе [0,3 мм (0,2–0,4) против 0,4 мм (0,2–0,5), <italic>р</italic> &lt;0,001], в то время как плотность железы значимо не различалась в обеих группах.</p> <p><bold>Заключение.</bold> Пациенты, которым проводили мультивисцеральную операцию, включающую панкреатодуоденальную резекцию, представляют собой контингент клинически более тяжёлых больных по общему физическому состоянию по сравнению с больными после панкреатодуоденальной резекции без резекции смежных органов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>multivisceral surgery</kwd><kwd>pancreaticoduodenectomy</kwd><kwd>pancreatic cancer</kwd><kwd>anesthetic risk</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мультивисцеральная операция</kwd><kwd>панкреатодуоденальная резекция</kwd><kwd>рак поджелудочной железы</kwd><kwd>анестезиологический риск</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Jin P, Liu H, Ma FH, et al. Retrospective analysis of surgically treated pT4b gastric cancer with pancreatic head invasion. World J Clin Cases. 2021;9(29):8718–8728. doi: 10.12998/wjcc.v9.i29.8718 EDN: PMGYSG</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Cojocari N, Crihana GV, Bacalbasa N, et al. Right-sided colon cancer with invasion of the duodenum or pancreas: A glimpse into our experience. Exp Ther Med. 2021;22(6):1378. doi: 10.3892/etm.2021.10813 EDN: QUKJXM</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Yan XL, Wang K, Bao Q, et al. En bloc right hemicolectomy with pancreatoduodenectomy for right-sided colon cancer invading duodenum. BMC Surg. 2021;21(1):302. doi: 10.1186/s12893-021-01286-0 EDN: XOQVPK</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Giuliani T, Di Gioia A, Andrianello S, et al. Pancreatoduodenectomy associated with colonic resections: indications, pitfalls, and outcomes. Updates Surg. 2021;73(2):379–390. doi: 10.1007/s13304-021-00996-7 EDN: GPRAYS</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Mizuno T, Ebata T, Yokoyama Y, et al. Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer. Br J Surg. 2019;106(5):626–635. doi: 10.1002/bjs.11088</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Patyutko YuI, Kudashkin NE, Kotelnikov AG. Surgical treatment of locally advanced cancer of the right half of the colon. Pelvic surgery and oncology. 2014;(2):28–32. EDN: SMGDTB</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Meng L, Huang Z, Liu J, et al. En bloc resection of a T4B stage cancer of the hepatic flexure of the colon invading the liver, gall bladder, and pancreas/duodenum: A case report. Clin Case Rep. 2020;8(12):3524–3528. doi: 10.1002/ccr3.3455 EDN: JQEVNO</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Zhu R, Grisotti G, Salem RR, Khan SA. Pancreaticoduodenectomy for locally advanced colon cancer in hereditary nonpolyposis colorectal cancer. World J Surg Oncol. 2016;14(1):12. doi: 10.1186/s12957-015-0755-7 EDN: AFKLFN</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Makuuchi R, Irino T, Tanizawa Y, et al. Pancreaticoduodenectomy for gastric cancer. Journal of Cancer Metastasis and Treatment. 2018;4:26. doi: 10.20517/2394-4722.2018.15</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Roberts P, Seevaratnam R, Cardoso R, et al. Systematic review of pancreaticoduodenectomy for locally advanced gastric cancer. Gastric Cancer. 2012;15 Suppl 1:S108–15. doi: 10.1007/s10120-011-0086-5 EDN: YDMKJB</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>D’Souza MA, Valdimarsson VT, Campagnaro T, et al; E-AHPBA scientific and research committee. Hepatopancreatoduodenectomy — a controversial treatment for bile duct and gallbladder cancer from a European perspective. HPB. 2020;22(9):1339–1348. doi: 10.1016/j.hpb.2019.12.008 EDN: CAFNZM</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Khalili M, Daniels L, Gleeson EM, et al. Pancreaticoduodenectomy outcomes for locally advanced right colon cancers: A systematic review. Surgery. 2019;166(2):223–229. doi: 10.1016/j.surg.2019.04.020</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Bosscher MR, van Leeuwen BL, Hoekstra HJ. Current management of surgical oncologic emergencies. PLoS One. 2015;10(5):e0124641. doi: 10.1371/journal.pone.0124641</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Friziero A, Sperti C, Riccio F, et al. Surgical oncological emergencies in octogenarian patients. Front Oncol. 2023;13:1268190. doi: 10.3389/fonc.2023.1268190 EDN: PQNUSE</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Skorus U, Rapacz K, Kenig J. The significance of comorbidity burden among older patients undergoing abdominal emergency or elective surgery. Acta Chir Belg. 2021;121(6):405–412. doi: 10.1080/00015458.2020.1816671 EDN: TCJAIQ</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Das B, Fehervari M, Hamrang-Yousefi S, et al. Pancreaticoduodenectomy with right hemicolectomy for advanced malignancy: a single UK hepatopancreaticobiliary centre experience. Colorectal Dis. 2023;25(1):16–23. doi: 10.1111/codi.16303 EDN: HHTXRO</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Solaini L, de Rooij T, Marsman EM, et al. Pancreatoduodenectomy with colon resection for pancreatic cancer: a systematic review. HPB. 2018;20(10):881–887. doi: 10.1016/j.hpb.2018.03.017</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Azam F, Latif MF, Farooq A, et al. Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals. Case Rep Oncol. 2019;12(3):728–736. doi: 10.1159/000503095</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Gugenheim J, Crovetto A, Petrucciani N. Neoadjuvant therapy for pancreatic cancer. Updates Surg. 2022;74(1):35–42. doi: 10.1007/s13304-021-01186-1 EDN: UCTVJY</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Chen JB, Luo SC, Chen CC, et al. Colo-pancreaticoduodenectomy for locally advanced colon carcinoma-feasibility in patients presenting with acute abdomen. World J Emerg Surg. 2021;16(1):7. doi: 10.1186/s13017-021-00351-6 EDN: OYBJWL</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Grewal K, Varner C. The emergency department is no place to be told you have cancer. CMAJ. 2024;196(18):E626–E627. doi: 10.1503/cmaj.240612 EDN: ZIBWJL</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Egorov VI, Akhmetzyanov FS, Kaulgud HA, Ruvinskiy DM. Clinical case of multivisceral en bloc resection for locally advanced cancer of the colon hepatic flexure. Kazan Medical Journal. 2024;105(4):669–676. doi: 10.17816/KMJ628774 EDN: IZFEIL</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Hipp J, Rist L, Chikhladze S, et al. Perioperative risk of pancreatic head resection-nomogram-based prediction of severe postoperative complications as a decisional aid for clinical practice. Langenbecks Arch Surg. 2022;407(5):1935–1947. doi: 10.1007/s00423-021-02426-z EDN: VRBHSJ</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Angrisani M, Sandini M, Cereda M, et al. Preoperative adiposity at bioimpedance vector analysis improves the ability of Fistula Risk Score (FRS) in predicting pancreatic fistula after pancreatoduodenectomy. Pancreatology. 2020;20(3):545–550. doi: 10.1016/j.pan.2020.01.008 EDN: JQZVRN</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Callery MP, Pratt WB, Kent TS, et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. Journal of the American College of Surgeons. 2013;216(1):1–14. doi: 10.1016/j.jamcollsurg.2012.09.002</mixed-citation></ref></ref-list></back></article>
